Methylprednisolone and Central nervous system viral infection - a phase IV clinical study of FDA data

Summary:

Central nervous system viral infection is reported as a side effect among people who take Methylprednisolone (methylprednisolone), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Tacrolimus, and have Transplant rejection.

The phase IV clinical study analyzes which people have Central nervous system viral infection when taking Methylprednisolone. It is created by eHealthMe based on reports of 58,374 people who have side effects when taking Methylprednisolone from the FDA, and is updated regularly.

What is Methylprednisolone?

Methylprednisolone has active ingredients of methylprednisolone. It is often used in inflammation. eHealthMe is studying from 59,645 Methylprednisolone users. Check the latest studies of Methylprednisolone.

What is Central nervous system viral infection?

Central nervous system viral infection is found to be associated with 9 drugs and 48 conditions by eHealthMe. Check the latest studies of Central nervous system viral infection.

On Aug, 05, 2026

58,374 people reported to have side effects when taking Methylprednisolone.
Among them, 15 people (0.03%) have Central nervous system viral infection.

Could Methylprednisolone cause Central nervous system viral infection?

Among these 15 people:

How long have people been on Methylprednisolone when they have Central nervous system viral infection? *

What is the gender of people who have Central nervous system viral infection when taking Methylprednisolone? *

female: 35.71 %
male: 64.29 %

What is the age of people who have Central nervous system viral infection when taking Methylprednisolone? *

What are other drugs people take besides Methylprednisolone? *

Tacrolimus: 15 people, 100.00%
Mycophenolate Mofetil: 13 people, 86.67%
Sulfamethoxazole And Trimethoprim: 3 people, 20.00%
Prednisone: 3 people, 20.00%
Cyclophosphamide: 3 people, 20.00%
Amphotericin B: 3 people, 20.00%
Voriconazole: 2 people, 13.33%
Valganciclovir Hydrochloride: 1 person, 6.67%
Solu-Medrol: 1 person, 6.67%
Sirolimus: 1 person, 6.67%

What are other side effects people have besides Central nervous system viral infection? *

Cardiac Infection (an infection of the heart): 9 people, 60.00%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 9 people, 60.00%
Orchitis (inflammation of the testes): 9 people, 60.00%
Pneumonia: 9 people, 60.00%
Lymphadenitis And Lymphangitis (inflammation or an infection of the lymphatic channels and lymph glands): 9 people, 60.00%
Kidney Infection: 9 people, 60.00%
Cardiac Arrest: 9 people, 60.00%
Oesophageal Infection: 9 people, 60.00%
Hepatic Infection: 9 people, 60.00%
Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin): 8 people, 53.33%

What are the existing conditions these people have? *

Transplant Rejection (a transplant material is not worked): 9 people, 60.00%
Pyelonephritis Acute (sudden inflammation of kidney caused by bacteria): 3 people, 20.00%
Immunodeficiency Disorders: 3 people, 20.00%
Post Transplant Lymphoproliferative Disorder: 2 people, 13.33%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 6.67%
Epstein-Barr Virus Associated Lymphoproliferative Disorder (lymphocytes are produced in excessive quantities associated with epstein-barr virus): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Methylprednisolone and have Central nervous system viral infection?

- Check whether Central nervous system viral infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Methylprednisolone:

Methylprednisolone (59,645 reports)

Central nervous system viral infection treatments and more:

Central nervous system viral infection (124 reports)

How severe was Central nervous system viral infection and when was it recovered:

Central nervous system viral infection in Methylprednisolone

Expand to all the drugs that have ingredients of methylprednisolone:

Central nervous system viral infection and drugs with ingredients of methylprednisolone

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Methylprednisolone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Central nervous system viral infection:

Central nervous system viral infection (9 drugs)

Browse all the conditions that are associated with Central nervous system viral infection:

Central nervous system viral infection (48 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on methylprednisolone (the active ingredients of Methylprednisolone) and Methylprednisolone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.